TechCrunch Disrupt 2026 has officially drawn to a close, having spent three electrifying days showcasing the immense talent, cutting-edge ingenuity, and relentless drive of the 2026 Startup Battlefield 200 cohort. Out of thousands of rigorous applications submitted from across the globe, the editorial and curation teams meticulously selected 200 of the most promising early-stage startups. […]
For decades, the pharmaceutical industry has relied heavily on animal models to test the safety and efficacy of emerging therapeutics. Yet, fundamental biological differences between species mean that a drug performing successfully in a mouse or a larger animal frequently fails when translated to human clinical trials. Most pharmaceutical candidates still ultimately fail during development, […]